AstraZeneca PLC Operating Income Over Time
| AZN Stock | USD 75.98 0.43 0.56% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out AstraZeneca PLC Performance and AstraZeneca PLC Correlation. AstraZeneca |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.207 | Dividend Share 2.9 | Earnings Share 2.03 | Revenue Per Share 2.5512 | Quarterly Revenue Growth 0.165 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare AstraZeneca PLC ADR and related stocks such as Novartis AG ADR, GlaxoSmithKline PLC ADR, and Roche Holding Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | 5.3 B | 11 B | 11.5 B | 10.9 B | 11.1 B | 9 B | 8.3 B | 8.6 B | 8.2 B | 9.1 B | 10.2 B | 26.9 B | 9.2 B | 9.8 B | 9.9 B |
| GSK | 619 M | 7.8 B | 7.4 B | 7 B | 3.6 B | 10.3 B | 2.6 B | 4.1 B | 5.5 B | 7 B | 7.8 B | 6.2 B | 6.4 B | 7 B | 5 B |
| BMY | 1.5 B | 6.6 B | 3.9 B | 2.9 B | 1.7 B | 1.7 B | 4.5 B | 3.5 B | 5.1 B | 5.5 B | 5.1 B | 10.2 B | 10.3 B | 17.2 B | 18.1 B |
| SNY | 971 M | 5.7 B | 15.7 B | 13 B | 12.6 B | 12.7 B | 12.3 B | 12 B | 12.4 B | 7.7 B | 8.1 B | 8.1 B | 16.8 B | 9.2 B | 8.7 B |
| MRK | 839.8 M | 9 B | 9.9 B | 7.7 B | 6.7 B | 7.5 B | 6 B | 7.3 B | 8.9 B | 9.2 B | 5.4 B | 10.6 B | 14.7 B | 3 B | 2.8 B |
| GILD | (4.8 M) | 3.8 B | 4 B | 4.5 B | 15.3 B | 22.2 B | 17.6 B | 14.1 B | 8.2 B | 4.3 B | 7 B | 7.4 B | 7.3 B | 7.6 B | 4.4 B |
| JNJ | 734.9 M | 16.3 B | 14.5 B | 15.4 B | 17.4 B | 15.3 B | 17.9 B | 14.2 B | 20.8 B | 21 B | 19.8 B | 24.4 B | 23.9 B | 21.9 B | 11.9 B |
| ABBV | 4.9 B | 3.6 B | 5.8 B | 5.7 B | 3.4 B | 7.5 B | 9.4 B | 9.6 B | 6.4 B | 13 B | 476 M | 17.9 B | 18.1 B | 17.4 B | 9.4 B |
| LLY | 764.4 M | 5.5 B | 4.7 B | 5.4 B | 2.7 B | 2.7 B | 3.5 B | 2.1 B | 6.2 B | 5 B | 6.1 B | 6.4 B | 7.1 B | 10.3 B | 10.8 B |
| PFE | 880 M | 18.2 B | 18 B | 16.4 B | 13.5 B | 13 B | 13.7 B | 14.1 B | 15 B | 15.1 B | 10.6 B | 24.8 B | 40 B | 4.2 B | 4 B |
| AMGN | (900 K) | 4.3 B | 5.6 B | 5.9 B | 6.2 B | 8.5 B | 9.8 B | 10 B | 10.3 B | 9.7 B | 5.8 B | 6 B | 5.3 B | 7.9 B | 4.1 B |
AstraZeneca PLC ADR and related stocks such as Novartis AG ADR, GlaxoSmithKline PLC ADR, and Roche Holding Operating Income description
Operating Income is the amount of profit realized from AstraZeneca PLC ADR operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of AstraZeneca PLC ADR is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| AstraZeneca PLC ADR | AZN |
 | CompulsionFama & French Classification |
| Location | United Kingdom |
| Exchange | NASDAQ Exchange |
USD 75.98
Check out AstraZeneca PLC Performance and AstraZeneca PLC Correlation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.